The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 11, Pages 3377
Publisher
MDPI AG
Online
2018-10-29
DOI
10.3390/ijms19113377
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Abscopal Effects With Hypofractionated Schedules Extending Into the Effector Phase of the Tumor-Specific T-Cell Response
- (2018) Xuanwei Zhang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Immune interconnectivity of anatomically distant tumors as a potential mediator of systemic responses to local therapy
- (2018) Rachel Walker et al. Scientific Reports
- Abscopal Benefits of Localized Radiotherapy Depend on Activated T-cell Trafficking and Distribution between Metastatic Lesions
- (2016) J. T. Poleszczuk et al. CANCER RESEARCH
- From concept to clinic: Mathematically informed immunotherapy
- (2016) Rachel Walker et al. CURRENT PROBLEMS IN CANCER
- Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
- (2016) Thomas H. P. M. Habets et al. PLoS One
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial
- (2015) Encouse B Golden et al. LANCET ONCOLOGY
- The different radiation response and radiation-induced bystander effects in colorectal carcinoma cells differing in p53 status
- (2015) Maria Widel et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- A proliferation saturation index to predict radiation response and personalize radiotherapy fractionation
- (2015) Sotiris Prokopiou et al. Radiation Oncology
- Connecting Radiation-Induced Bystander Effects and Senescence to Improve Radiation Response Prediction
- (2015) Jan Poleszczuk et al. RADIATION RESEARCH
- Current Clinical Trials Testing Combinations of Immunotherapy and Radiation
- (2015) Marka Crittenden et al. SEMINARS IN RADIATION ONCOLOGY
- A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab
- (2015) Ravi A Chandra et al. OncoImmunology
- Combinations of Immunotherapy and Radiation in Cancer Therapy
- (2014) Ralph E. Vatner et al. Frontiers in Oncology
- Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
- (2013) Silvia C. Formenti et al. JNCI-Journal of the National Cancer Institute
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Radiation-Induced Bystander Effects: What Are They, and How Relevant Are They to Human Radiation Exposures?
- (2011) Benjamin J. Blyth et al. RADIATION RESEARCH
- Anti–CTLA-4 Antibody Therapy: Immune Monitoring During Clinical Development of a Novel Immunotherapy
- (2010) Margaret K. Callahan et al. SEMINARS IN ONCOLOGY
- Invariant Natural Killer T Cells Regulate Breast Cancer Response to Radiation and CTLA-4 Blockade
- (2009) K. A. Pilones et al. CLINICAL CANCER RESEARCH
- Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti-CTLA-4 Antibody
- (2009) M. Z. Dewan et al. CLINICAL CANCER RESEARCH
- The Mechanism of Anti-CTLA-4 Activity and the Negative Regulation of T-Cell Activation
- (2008) J. D. Wolchok et al. ONCOLOGIST
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started